Personal Care Products

Interparfums, Inc. and Marquee Brands announced a 20-year extension of Interparfums' exclusive worldwide license agreement for Roberto Cavalli and Just Cavalli fragrances, carrying the partnership through December 31, 2046. The deal covers continued creation, development and distribution of the fragrances globally, operated by Interparfums Italia Srl, the company's wholly owned Italian subsidiary based in Florence with its seat of management in Paris. Interparfums Chairman and Chief Executive Officer Jean Madar said the extension reflects the strength of Roberto Cavalli and the partnership with Marquee Brands, noting that in three years managing the license the brand has become one of the fastest-growing in the company's portfolio, with the 2025 launch of Serpentine exceeding expectations. Marquee Brands Chief Executive Officer Heath Golden said Interparfums has proven an exceptional steward of Roberto Cavalli fragrances and that extending the partnership across decades reflects the long-term role fragrance will play in the brand's global growth strategy. Interparfums has operated in the global fragrance business since 1982 and manages European operations through its 72% owned subsidiary Interparfums SA and United States operations through wholly owned subsidiaries in the United States and Italy.

Market Connections Asia Public Company Limited, or MCA, has notified the Stock Exchange of Thailand that Rojukiss International Public Company Limited, a manufacturer and distributor of skincare products under the ROJUKISS trademark and cosmetics under the SIS2SIS trademark, has appointed MCA as a distributor of skincare products under the ROJUKISS trademark in the cream and serum categories, and cosmetics under the SIS2SIS trademark, through Traditional Trade channels nationwide, effective from 1 October 2026 onwards.

Estee Lauder Companies has entered a global strategic partnership with AI marketing platform Profound to improve how its brands appear across generative AI platforms. The collaboration gives Estee Lauder a portfolio-wide view of how its brands surface on major generative AI platforms including ChatGPT and Gemini, and makes it the first prestige beauty company to deploy Profound's capabilities globally across its full portfolio and implement Generative Engine Optimization at scale. Profound's agentic tools will optimize product pages, blogs, YouTube channels and other digital content so that product information, ingredients, claims and benefits are easier for large language models to understand and surface, with AI visibility insights integrated into Estee Lauder's One Operating Ecosystem. The initiative builds on Estee Lauder's digital exposure, with online sales reaching 34% of reported sales in fiscal 2026, up three percentage points year over year. Shares of the Zacks Rank #3 (Hold) company have gained 14.1% in the past month, and the stock trades at a forward 12-month P/E ratio of 27.97 versus an industry average of 22.15.

e.l.f. Beauty is expanding its international footprint with the launch of e.l.f. Cosmetics in Brazil exclusively through Sephora, becoming Sephora Brazil's first mass color cosmetics offering. Sephora's Brazilian platform reaches roughly 17% of the country's population, and the move builds on the brand's relationship with Sephora in Mexico, where it has reached the No. 1 cosmetics position. International sales penetration has doubled over the past five years to 21% of net sales, still well below the more than 70% international mix cited for legacy beauty peers, and Brazil is identified as the world's third-largest cosmetics market. International net sales rose 61% year over year in the fiscal first quarter compared with 29% growth in the United States, and an expanded presence with Boots in the U.K. is planned for this fall. Shares of ELF have tumbled 33.4% over the past year compared with the industry's decline of 2.3%, and the stock trades at a forward price-to-earnings ratio of 25.76 versus the industry's average of 22.15.

Herbalife's board approved a new $250 million share buyback on September 8, to be spread across the next three years, a vote of confidence in a stock trading in the single digits with a battered balance sheet. CFO John DeSimone framed the repurchase as a reflection of free cash flow generation and flexibility to keep investing in the business, and the second quarter, reported August 5, brought net sales of $1.3 billion, up 5.4% year over year and at the top of guidance, or 5.8% in constant currency, marking the fourth straight quarter of year-over-year sales expansion on both a reported and constant currency basis. Latin America led with net sales up 16.6%, while Asia Pacific rose 15.2%, or 23.1% at constant currency, and adjusted EBITDA of $166.6 million landed near the top of the guided range, beating guidance outright at $174.4 million in constant currency. The same quarter produced a net loss attributable to the company of $26.3 million, driven largely by a $94.6 million charge tied to extinguishing debt after an April refinancing, with gross margin slipping to 77.7% from 78.0% and adjusted EBITDA margin down 120 basis points to 12.6%, while China sales dropped 24.5% as reported and 29.0% at constant currency and EMEA fell 3.5%, or 5.6% adjusting for currency. Management narrowed full-year 2026 guidance, trimming the reported adjusted EBITDA range to $670 million to $690 million from a prior $675 million to $705 million on FX headwinds even as the constant currency outlook was raised, and DeSimone is set to retire at the end of 2026, handing the CFO role to Scott Schaefer on January 1, 2027, with the balance sheet still carrying a total shareholders' deficit of $466.9 million as of June 30 alongside more than $2 billion in long-term debt.

dsm-firmenich repurchased 385,000 of its own shares during the period from September 7, 2026 up to and including September 11, 2026, at an average price of €92.07 per share for a total amount of €35.4 million. The purchases are part of a repurchase program the company announced on February 9, 2026, covering ordinary shares with an aggregate market value of €500 million to reduce its issued capital, and which it began executing on March 12, 2026 for a total of €540 million. That €540 million total comprises €40 million to cover commitments under the Group's share-based compensation plans and €500 million to reduce issued capital. The €40 million portion earmarked for share-based compensation plans was finalized on March 23, 2026, while the €500 million capital-reduction program is intended to be completed by the end of Q3 2026. To date, 6,402,212 shares have been repurchased under the program at an average price of €72.91, for a total consideration of €466.8 million.

Estée Lauder is partnering with AI marketing platform Profound to help the company see how its brands appear across generative AI platforms and identify ways to improve visibility. By using Profound's findings, Estée Lauder can optimize content across social media and product description pages, ensuring product information, ingredients, claims, and benefits are optimized for consumer visibility and easier for large language models to understand and surface to consumers. "The way people discover beauty is being rewritten in real time, and we intend to shape that shift rather than reacting to it," said Aude Gandon, Estée Lauder's global chief digital and marketing officer. Profound's CEO and co-founder James Cadwallader added that enabling this strategy at scale across an entire prestige beauty portfolio sets a new bar for what enterprise AI visibility strategy looks like in this category.

Shiseido announced its financial results for the first half of the fiscal year ending December 2026, reporting operating profit of 41.9 billion yen, up 131.8% from the same period a year earlier. Sales revenue came to 498.9 billion yen, up 6.2% year on year, while net profit was 29.6 billion yen, up 211.4%, and earnings per share stood at 74.32 yen. In the immediately preceding fiscal year ended December 2025, sales revenue was 969.9 billion yen, down 2.1%, with an operating loss of 28.7 billion yen and a net loss of 40.6 billion yen, meaning the company has swung back into profit from a loss-making period. The company formulated its Action Plan 2025-2026 in November 2024 and says it completed key structural reform measures in the prior fiscal year toward achieving a core operating profit margin of 7% in 2026. Its full-year forecast calls for sales revenue of 990 billion yen, up 2.1%, operating profit of 59 billion yen, net profit of 42 billion yen, and an annual dividend of 60 yen, with the first-half operating profit of 41.9 billion yen reaching 71% of the full-year forecast.

Botanee announced on the evening of September 11 that its wholly owned subsidiary, Shanghai Botanee Health Technology Co., Ltd., received the Medical Device Registration Certificate of the People's Republic of China from the National Medical Products Administration on September 10. The product is an injectable sodium hyaluronate solution. The announcement shows that the product is used in medical institutions for superficial injection into the facial dermis to temporarily improve adult skin dryness and dull complexion. The company stated that obtaining the medical device registration certificate further supplements its medical device product line in the skin health field, complements its existing functional skincare products and related businesses, enriches its product matrix, and helps further enhance its core competitiveness and comprehensive market expansion capabilities.

Dao Securities (Thailand) Public Company Limited issued an analysis dated September 11, 2026, giving a positive view on Neo Corporate Public Company Limited, or NEO, following the Ministry of Finance's ongoing expedited consideration of extending the Thai Chai Thai Plus Phase 2 program, after energy prices remain high and the war situation has not ended. Deputy Prime Minister and Finance Minister Ekniti Nitithanprapas disclosed that there are still funds remaining for relief measures and that the majority of voices support extending the program by about one to two months. A conclusion is expected within two to three weeks, or by the end of September. Currently, about 26 million people have joined the Thai Chai Thai Plus program, and there are about 13 million state welfare card users, bringing the total base of beneficiaries from government measures to about 40 million people. Dao Securities views that if the Thai Chai Thai Plus Phase 2 program is extended, it will help support revenue in the fourth quarter of 2026 to continue expanding and give profit in that period a chance to grow compared with the same period last year by more than previously estimated. Previously, fourth-quarter 2026 profit was expected to slow both year on year and quarter on quarter after the end of the Thai Chai Thai Plus Phase 1 program. For the third quarter of 2026, Dao Securities expects NEO's profit to grow outstandingly year on year and hold steady quarter on quarter, supported by revenue that is likely to set continuous new records from growth in all product groups, especially domestic revenue that benefits from a full quarter of the Thai Chai Thai Plus program, together with product price increases starting in July 2026. Meanwhile, the gross profit margin is expected to expand year on year but may decline slightly from the previous quarter due to recognition of depreciation from the new Household product group factory. For the full-year 2026 estimate, Dao Securities still expects NEO's net profit at 642 million baht, up 14% year on year, supported by total revenue expected to expand 12% year on year, driven by revenue growth in all product groups, especially the Household and Personal Care groups, which are likely to grow outstandingly. However, the full-year gross profit margin is expected to decline slightly from the impact of the war situation, while the ratio of selling and administrative expenses to sales is likely to decrease from more efficient expense control. Dao Securities maintains its buy recommendation on NEO and a target price of 31.00 baht, based on a 2026 PER of 14.5 times, or 0.5 standard deviation above the average since listing on the stock exchange. It views the current valuation level as still attractive, as it trades at a PER of only 11.2 times, close to 0.75 standard deviation below the average since listing, and does not yet reflect the trend of profit returning to growth during 2026-2027.

Botanee announced that its wholly-owned subsidiary, Shanghai Botanee Health Technology, has obtained a Medical Device Registration Certificate from the National Medical Products Administration for its injectable sodium hyaluronate solution. The registration number is 20263131919, effective September 10, 2026, and valid until September 9, 2031. The product is intended for superficial dermal injection in the mid-face in medical institutions to temporarily improve dry skin and dull complexion in adults. In the first half of 2026, Botanee achieved revenue of 2.592 billion yuan and net profit attributable to the parent of 292 million yuan.

Betaini announced that its wholly-owned subsidiary, Shanghai Betaini Health Technology Co., Ltd., received a medical device registration certificate from the National Medical Products Administration on September 10, 2026. The product is an injectable sodium hyaluronate solution for superficial dermal injection in the face, temporarily improving adult skin dryness and dull complexion. The company stated that this product further supplements its medical device product line in the skin health field, enriches its product matrix, and helps enhance core competitiveness.

e.l.f. Beauty, Inc. reported a 61% year-over-year increase in international net sales for the first quarter of fiscal 2027, outpacing the 29% growth in the United States, with international penetration now representing 21% of total net sales, up from about 10% five years ago. The growth is driven by broader retail distribution, deeper market penetration, and new brand launches, including strong performance in the UK and Germany, where the e.l.f. brand saw improved trends after launching at DM and resuming marketing efforts. Naturium, which launched with Sephora in Australia and New Zealand, has become the No. 1 body brand at Sephora in those markets and will enter Sephora in Canada and Mexico this fall. rhode has achieved record-setting launches with Sephora in North America and the UK and with Mecca in Australia and New Zealand, reaching the No. 1 beauty-brand ranking at both retailers. e.l.f. Beauty is also expanding into Brazil through Sephora this fall, building on its No. 1 cosmetics-brand ranking with Sephora in Mexico. Shares of e.l.f. Beauty have gained 87.3% over the past three months, outperforming the industry and the S&P 500, which rose 27.1% and 3.5%, respectively. The stock trades at a forward P/E of 28.17, above the industry average of 23.73 and the sector average of 17.02.

ODDITY shares jumped 14% on Thursday after the company posted second-quarter results that topped Wall Street estimates and issued a stronger-than-expected full-year profit outlook. The consumer tech company reported revenue of $181 million for the quarter, beating estimates of $178 million but down 25% from a year earlier. Adjusted earnings per share came in at $0.20, ahead of the $0.16 estimate, while adjusted EBITDA reached $13 million, more than the $8.8 million analysts had projected. For fiscal 2026, ODDITY guided adjusted EBITDA of $30 million to $32 million, well above the $10.7 million estimate, with revenue expected to decline 19% year-over-year. For the third quarter, the company forecast adjusted EBITDA of $18 million to $20 million against estimates of $6.3 million, with revenue seen down 5% from a year earlier. Gross margin was 68.7%, down 360 basis points from a year ago. Net income for the quarter was $13 million, and the company held $561 million in cash, cash equivalents and investments. "We made progress during the quarter, including strong results for both SpoiledChild and METHODIQ," said Oran Holtzman, ODDITY co-founder and CEO. "We remain hopeful that IL MAKIAGE is on track to achieve normalization and we continue to work in close partnership with our largest advertising partner to solve the technical issue." ODDITY is a consumer tech company that uses AI and data science to build digital-first beauty and wellness brands, including IL MAKIAGE, SpoiledChild and METHODIQ, serving over 70 million users.

dsm-firmenich has provided a weekly update on its share repurchase program, which was announced on February 9, 2026, to repurchase shares worth €500 million and reduce issued capital. The program was expanded on March 12, 2026, to a total of €540 million, with €40 million earmarked for share-based compensation plans and €500 million for capital reduction. Between August 31 and September 4, 2026, the company repurchased 275,000 shares at an average price of €94.52 per share, totaling €26.0 million. To date, the company has repurchased 6,017,212 shares at an average price of €71.69, for a total consideration of €431.4 million. The €40 million buyback for compensation plans was completed on March 23, 2026, and the €500 million capital reduction program is expected to conclude by the end of Q3 2026.

BIC has announced its strategic roadmap to 2030, aiming to reignite consistent organic growth, strengthen profitability, and enhance cash generation. The plan, named BIC to the Future, focuses on four everyday essentials categories—Stationery, Lighters, Shavers, and Brushes—with a simplified portfolio and consumer-centric offerings. The company targets an organic net sales compound annual growth rate of approximately 3% from 2026 to 2030, an adjusted EBIT margin above 15.5% by 2030, and free cash flow exceeding 250 million euros in 2030, with cumulative free cash flow of 900 to 950 million euros from 2027 to 2030. To support these goals, BIC will invest about 100 million euros in operational expenditures from 2027 to 2030, expecting annualized recurring savings of 80 million euros by 2030. The company also plans to maintain a growing dividend with a payout ratio between 40% and 50% of adjusted earnings per share.

88 (Thailand) or 88TH expects its Q3/2026 revenue to continue growing, supported by the gradual recognition of revenue from new products under the LYO brand, including LYO My Color, LYO Hair Oil, and LYO Silver Block, which have already been launched. The company is also preparing to introduce 6 more SKUs of cosmetics and 4 SKUs of skincare under the Hone brand to boost sales in the final stretch of the year. Meanwhile, the online channel's revenue share has increased to 29%, up from 21% in Q2/2026. The company will accelerate social commerce and live commerce efforts, expand into international markets, and prepare to enter the pet products business through its subsidiary Monster Lab, with revenue recognition expected to begin in Q4/2026. However, risk factors to monitor include intense competition in the beauty market, especially from Chinese brands competing on price and rapid product development, as well as potential increases in raw material costs and online fees.

88 (Thailand) Public Company Limited, or 88TH, has revealed its operational outlook for Q3/69, expecting support from the gradual recognition of revenue from new products, while expanding online channels and international markets ahead of the launch of its pet food business in Q4/69 to build a long-term revenue base. Ms. Wiraya Phanphiboon, Chief Financial Officer, stated during the Earnings Call that the company plans to launch a total of 6 SKUs of cosmetics and 4 SKUs of skincare products. Meanwhile, products under the Lyo brand will gradually recognize revenue from Lyo Hair Color, Lyo Hair Oil, and Lyo Fever starting from Q3/69. As for the pet food business under its subsidiary Monster Lab, commercial preparations are underway in Q3/69, with actual sales expected to begin in Q4/69 through e-commerce channels, pet food stores, and modern trade. The company will continue to incur marketing expenses to build brand awareness and promote new products, but will focus on managing the budget in line with sales and returns. Key risk factors to monitor include intense competition in both pricing and products, the entry of Chinese cosmetic brands, changing consumer behavior driven by the Fast Beauty trend, volatility in raw material and logistics costs due to the Middle East conflict, and the potential increase in fees charged by online platforms.

Betaini announced on September 2 that as of August 31, 2026, the company had repurchased a total of 3.7 million shares through centralized bidding, accounting for 0.8734% of total share capital, with a total transaction amount of 120 million yuan. The highest repurchase price was 34.67 yuan per share, and the lowest was 29.84 yuan per share. In the first half of 2026, Betaini achieved revenue of 2.592 billion yuan and net profit attributable to the parent of 292 million yuan.

Pigeon announced on the 1st that it will raise the shipping prices of some baby-related products, including nursing bottles, for orders received from November 2nd. The price increase covers 243 items, with the maximum increase reaching 36%. The company cited rising raw material and logistics costs as the reason, and this price hike is likely to increase the burden on families raising children.

Pigeon announced on the 1st that it will raise the shipping prices of some baby-related products, including baby bottles, for orders received from November 2nd. The reason is the surge in raw material costs and logistics expenses, and the price increase applies to 243 items, with a maximum increase of 36%. Specifically, the "Natural Feel Baby Bottle (Heat-Resistant Glass) 240ml" will go up from 2,860 yen to 2,970 yen, and the "Milk Tooth Brush First Set" will go up from 1,386 yen to 1,430 yen. In addition, 46 nursing care-related products sold by group company Pigeon Tahira (Tokyo) will also see shipping prices raised by up to 23% from November 2nd.

Pigeon announced on the 1st that it will raise the shipping prices of some baby-related products, including baby bottles, for orders received from November 2nd. The reason is the surge in raw material costs and logistics costs. The target is 243 items, with a maximum increase of 36%. For example, the "Natural Feel Baby Bottle (Heat-Resistant Glass) 240ml" will go from 2,860 yen to 2,970 yen, and the "Milk Tooth Brush First Set" will go from 1,386 yen to 1,430 yen. In addition, the group company Pigeon Tahira (Tokyo) will also raise shipping prices for 46 nursing care-related products by up to 23% from November 2nd.

SNPS is moving forward with expanding its Thai herbal business capabilities by building a new plant in Bang Phli, which will be completed by the end of 2026, to support the production of medicines and medical devices derived from active ingredients of herbal plants. The company targets revenue growth of 15-30% this year compared to the previous year and believes its performance will still meet targets, as the first half of the year saw total revenue of 259.19 million baht. It also maintains a gross profit margin of around 40% and a net profit margin of around 17%. Meanwhile, the new plant has a construction investment budget of approximately 175.90 million baht and a land lease contract budget of around 50.48 million baht over a 30-year period. According to an analysis by Yuanta Securities (Thailand), normal profit in the second half of 2026 is expected to recover from the first half, reaching 26 million baht per quarter, due to the illness season and revenue from new products in the artificial saliva group. However, profit will still decline compared to the same period last year due to weak gross profit margins. The normal profit estimates for 2026-2027 are 96 million baht and 113 million baht, respectively.

e.l.f. Beauty shares hit their highest level since November after the company announced that its rhode beauty brand will launch at Sephora across Europe on September 30, following its U.S. and Canada rollout last year. The Hailey Bieber-founded brand, acquired by e.l.f. Beauty in 2025 for $1 billion, has become the company's primary revenue growth engine, posting 36% sales growth in the fiscal first quarter. To build anticipation, rhode hosted events including a beach club in Mallorca and a summer station tour in Amalfi and Copenhagen. e.l.f. Beauty shares rose more than 4% on Monday.